De Visschere Pieter, Bertolotto Michele, Belfield Jane, Campo Irene, Corcioni Beniamino, Derchi Lorenzo, Dogra Vikram, Gaudiano Caterina, Huang Dean Y, Kozak Oliwia, Lotti Francesco, Markiet Karolina, Nikolic Olivera, Pavan Nicola, Pasoglou Vassiliki, Ramanathan Subramaniyan, Richenberg Jonathan, Rocher Laurence, Sachs Camilla, Sidhu Paul S, Skrobisz Katarzyna, Studniarek Michal, Tsili Athina, Secil Mustafa
Department of Radiology and Nuclear Medicine, Ghent University Hospital, Ghent, Belgium.
Department of Radiology, University of Trieste, Ospedale di Cattinara, Trieste, Italy.
Eur Radiol. 2025 Jan 25. doi: 10.1007/s00330-025-11380-z.
The Scrotal and Penile Imaging Working Group (SPIWG) of the European Society of Urogenital Radiology (ESUR) aimed to formulate recommendations on the imaging modalities and minimal technical requirements for abdominopelvic imaging in the follow-up of adult patients treated for testicular germ-cell tumors (TGCT).
The SPIWG members performed an extensive literature search, reviewed the current clinical practice, and reached a consensus based on the opinions of experts in the field.
Recurrence in patients treated for TGCT mainly occurs in retroperitoneal lymph nodes (LNs). Abdominopelvic CT and MRI are equivalent assessing retroperitoneal LNs. MRI has the advantage of avoiding radiation exposure, and moreover, diffusion-weighted images (DWI) may increase the detection rates without the need for contrast administration. In patients treated for stage I TGCT, the ESUR-SPIWG recommends MRI over CT for the detection of retroperitoneal LNs during the follow-up after treatment. CT, however, remains the follow-up imaging of choice in patients with advanced disease. When MRI is used, the recommended minimal requirements are at least one high-quality anatomical sequence (T1-WI or T2-WI) in axial and coronal planes, and DWI in the same axial plane, ≤ 4 mm contiguous slices from the diaphragm to the perineum. When CT is used, the recommended minimal requirement is a standard-dose contrast-enhanced CT in the portal-venous phase, scanned from the diaphragm to the perineum.
In this paper, the ESUR-SPIWG provides recommendations on the imaging modalities and minimal technical requirements for abdominopelvic imaging in the follow-up of adult patients treated for TGCT.
Question There are no recommendations on the preferred imaging modality or scan sequences required for abdominopelvic imaging in the follow-up after treatment for testicular cancers. Findings The European Society of Urogenital Radiology Scrotal and Penile Imaging Working Group (ESUR-SPIWG) provides recommendations for abdominopelvic imaging in follow-up after treatment for testicular cancers. Clinical relevance Recurrence of testicular germ-cell tumors mainly occurs in retroperitoneal lymph nodes. Both CT and MRI provide similar morphological assessments, but radiation exposure can be avoided by using MRI instead of CT.
欧洲泌尿生殖放射学会(ESUR)阴囊和阴茎成像工作组(SPIWG)旨在针对接受睾丸生殖细胞肿瘤(TGCT)治疗的成年患者随访中的腹部盆腔成像的成像方式和最低技术要求制定建议。
SPIWG成员进行了广泛的文献检索,回顾了当前的临床实践,并基于该领域专家的意见达成了共识。
接受TGCT治疗的患者复发主要发生在腹膜后淋巴结(LN)。腹部盆腔CT和MRI在评估腹膜后LN方面等效。MRI具有避免辐射暴露的优势,此外,扩散加权成像(DWI)可能无需使用对比剂即可提高检出率。对于接受I期TGCT治疗的患者,ESUR-SPIWG建议在治疗后的随访期间,使用MRI而非CT来检测腹膜后LN。然而,CT仍然是晚期疾病患者随访成像的首选。使用MRI时,推荐的最低要求是在轴位和冠状位至少有一个高质量的解剖序列(T1加权成像或T2加权成像),以及在同一轴位平面的DWI,从膈肌到会阴的连续层厚≤4mm。使用CT时,推荐的最低要求是门静脉期的标准剂量对比增强CT,从膈肌扫描至会阴。
在本文中,ESUR-SPIWG提供了关于接受TGCT治疗的成年患者随访中腹部盆腔成像的成像方式和最低技术要求的建议。
问题 对于睾丸癌治疗后随访中的腹部盆腔成像,没有关于首选成像方式或扫描序列的建议。 发现 欧洲泌尿生殖放射学会阴囊和阴茎成像工作组(ESUR-SPIWG)提供了睾丸癌治疗后随访中腹部盆腔成像的建议。 临床意义 睾丸生殖细胞肿瘤的复发主要发生在腹膜后淋巴结。CT和MRI提供相似的形态学评估,但使用MRI代替CT可避免辐射暴露。